This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

The fifth edition of the World Health Organization (WHO) histologic classification of thyroid
neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a …

Abstract DICER1 syndrome (OMIM 606241, 601200) is a rare autosomal dominant familial
tumor predisposition disorder with a heterozygous DICER1 germline mutation. The most …

This review of the familial tumor syndromes involving the endocrine organs is focused on
discussing the main updates on the upcoming fifth edition of the WHO Classification of …

The thyroid is the most common site of endocrine cancer. One type of thyroid cancer, non-
medullary thyroid cancer (NMTC), develops from follicular cells and represents …

Our understanding of the genomics and epigenomics of medullary thyroid carcinoma (MTC)
has advanced since the initial recognition of RET as a driver of MTC tumorigenesis in …

Tumors with papillary cribriform and morular architecture were initially considered to be
variants of papillary thyroid carcinoma; however, recent observations have challenged this …

Papillary thyroid carcinoma is the most common type of thyroid malignancy both in adults
and pediatric population. Since the 1980s, there are changes in criteria in labelling thyroid …

Thyroid cancer, a cancerous tumor or growth located within the thyroid gland, is the most
common endocrine cancer. It is one of the few cancers whereby incidence rates have …

Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) are both well-
differentiated thyroid cancers derived from thyroid follicular epithelium. Apart from this …